Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility
Alembic Pharmaceuticals said the USFDA completed an unannounced inspection of its Vadodara bioequivalence facility with no Form 483 observations
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.